Search details
1.
Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals.
J Allergy Clin Immunol
; 142(5): 1548-1557, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29366701
2.
Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses.
Cytometry A
; 93(8): 793-802, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30168890
3.
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
J Immunol
; 197(1): 168-78, 2016 07 01.
Article
in English
| MEDLINE | ID: mdl-27217584
4.
Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping.
Clin Immunol
; 157(2): 261-76, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25572534
5.
Fcγ receptors inhibit mouse and human basophil activation.
J Immunol
; 189(6): 2995-3006, 2012 Sep 15.
Article
in English
| MEDLINE | ID: mdl-22908332
6.
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors.
J Immunother Cancer
; 12(4)2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38631710
7.
A strain of Lactobacillus casei inhibits the effector phase of immune inflammation.
J Immunol
; 187(5): 2646-55, 2011 Sep 01.
Article
in English
| MEDLINE | ID: mdl-21810608
8.
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC.
Sci Adv
; 9(45): eadh0708, 2023 11 10.
Article
in English
| MEDLINE | ID: mdl-37939189
9.
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Cancer Discov
; 13(4): 858-879, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36669143
10.
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
Proc Natl Acad Sci U S A
; 106(41): 17469-74, 2009 Oct 13.
Article
in English
| MEDLINE | ID: mdl-19805141
11.
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers.
J Immunother Cancer
; 10(2)2022 02.
Article
in English
| MEDLINE | ID: mdl-35131864
12.
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.
Lung Cancer
; 166: 255-264, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34953624
13.
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
J Immunother Cancer
; 10(7)2022 07.
Article
in English
| MEDLINE | ID: mdl-35896284
14.
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
J Immunother Cancer
; 10(5)2022 05.
Article
in English
| MEDLINE | ID: mdl-35640928
15.
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
J Exp Clin Cancer Res
; 41(1): 217, 2022 Jul 07.
Article
in English
| MEDLINE | ID: mdl-35794623
16.
Type 17 CD8+ T cells display enhanced antitumor immunity.
Blood
; 114(3): 596-9, 2009 Jul 16.
Article
in English
| MEDLINE | ID: mdl-19471017
17.
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Blood
; 114(3): 535-46, 2009 Jul 16.
Article
in English
| MEDLINE | ID: mdl-19451549
18.
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer.
Transl Lung Cancer Res
; 10(6): 2937-2954, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34295689
19.
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation.
Cancers (Basel)
; 13(8)2021 Apr 13.
Article
in English
| MEDLINE | ID: mdl-33924378
20.
Interleukin-7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren's Syndrome.
Arthritis Rheumatol
; 73(4): 631-640, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33058491